Animals, Agriculture & Food
H3 Equine Influenza A Virus
WARF: P05092US
Inventors: Christopher Olsen, Gabriele Landolt, Alexander Karasin
The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in an isolated H3 equine influenza A virus that could be used for vaccine development.
Overview
Influenza is a major respiratory disorder that affects humans and many animals, including horses. New strains of influenza arise frequently, creating a continuous need to isolate new influenza viruses for vaccine production.
The Invention
UW-Madison researchers have developed an isolated H3 equine influenza A virus, as well as methods of preparing and using the virus. This virus, which was isolated following a May 2003 outbreak of respiratory disease in horses, represents a new line of equine influenza virus. It is genetically related to a virus that caused an outbreak of influenza among horses in South Africa and to a virus isolated from greyhound dogs in Florida. This virus will be useful as part of an up-to-date vaccine against equine influenza.
Applications
- Equine influenza vaccines
Key Benefits
- Provides a potential new influenza strain for equine and possibly canine vaccine development
Additional Information
Related Intellectual Property
- View Divisional Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
- View Continuation Patent in PDF format.
Tech Fields
For current licensing status, please contact Emily Bauer at [javascript protected email address] or 608-960-9842